The latest quarter not only was better than the year-ago period for Johnson & Johnson consumer health business sales, it also was likely better than the segment will do for the remainder of 2021, the firm joins analysts in saying.
In the first of what could be similar earnings results for the April-June period from other major consumer health and personal care product manufacturers, J&J on 21 July reported 9